288 related articles for article (PubMed ID: 32393492)
1. Polymyxin Triple Combinations against Polymyxin-Resistant, Multidrug-Resistant, KPC-Producing Klebsiella pneumoniae.
Aye SM; Galani I; Yu H; Wang J; Chen K; Wickremasinghe H; Karaiskos I; Bergen PJ; Zhao J; Velkov T; Giamarellou H; Lin YW; Tsuji BT; Li J
Antimicrob Agents Chemother; 2020 Jul; 64(8):. PubMed ID: 32393492
[TBL] [Abstract][Full Text] [Related]
2. Polymyxin B in Combination with Rifampin and Meropenem against Polymyxin B-Resistant KPC-Producing Klebsiella pneumoniae.
Diep JK; Jacobs DM; Sharma R; Covelli J; Bowers DR; Russo TA; Rao GG
Antimicrob Agents Chemother; 2017 Feb; 61(2):. PubMed ID: 27872078
[TBL] [Abstract][Full Text] [Related]
3. Novel Polymyxin Combination with the Antiretroviral Zidovudine Exerts Synergistic Killing against NDM-Producing Multidrug-Resistant Klebsiella pneumoniae.
Lin YW; Abdul Rahim N; Zhao J; Han ML; Yu HH; Wickremasinghe H; Chen K; Wang J; Paterson DL; Zhu Y; Rao GG; Zhou QT; Forrest A; Velkov T; Li J
Antimicrob Agents Chemother; 2019 Apr; 63(4):. PubMed ID: 30670431
[TBL] [Abstract][Full Text] [Related]
4.
Huang D; Yu B; Diep JK; Sharma R; Dudley M; Monteiro J; Kaye KS; Pogue JM; Abboud CS; Rao GG
Antimicrob Agents Chemother; 2017 Jul; 61(7):. PubMed ID: 28438930
[TBL] [Abstract][Full Text] [Related]
5. Polymyxin Combinations Combat
Bulman ZP; Chen L; Walsh TJ; Satlin MJ; Qian Y; Bulitta JB; Peloquin CA; Holden PN; Nation RL; Li J; Kreiswirth BN; Tsuji BT
mBio; 2017 Jul; 8(4):. PubMed ID: 28743810
[TBL] [Abstract][Full Text] [Related]
6. Polymyxin B and fosfomycin thwart KPC-producing Klebsiella pneumoniae in the hollow-fibre infection model.
Bulman ZP; Zhao M; Satlin MJ; Chen L; Kreiswirth BN; Walsh TJ; Nation RL; Li J; Tsuji BT
Int J Antimicrob Agents; 2018 Jul; 52(1):114-118. PubMed ID: 29486233
[TBL] [Abstract][Full Text] [Related]
7. New Polymyxin B Dosing Strategies To Fortify Old Allies in the War against KPC-2-Producing Klebsiella pneumoniae.
Bulman ZP; Satlin MJ; Chen L; Kreiswirth BN; Shin BS; Walsh TJ; Holden PN; Forrest A; Nation RL; Li J; Tsuji BT
Antimicrob Agents Chemother; 2017 Apr; 61(4):. PubMed ID: 28167549
[TBL] [Abstract][Full Text] [Related]
8. In Vitro Activity of Polymyxin B in Combination with Various Antibiotics against Extensively Drug-Resistant Enterobacter cloacae with Decreased Susceptibility to Polymyxin B.
Cai Y; Lim TP; Teo J; Sasikala S; Lee W; Hong Y; Chan EC; Tan TY; Tan TT; Koh TH; Hsu LY; Kwa AL
Antimicrob Agents Chemother; 2016 Sep; 60(9):5238-46. PubMed ID: 27324776
[TBL] [Abstract][Full Text] [Related]
9. Synergistic killing of NDM-producing MDR Klebsiella pneumoniae by two 'old' antibiotics-polymyxin B and chloramphenicol.
Abdul Rahim N; Cheah SE; Johnson MD; Yu H; Sidjabat HE; Boyce J; Butler MS; Cooper MA; Fu J; Paterson DL; Nation RL; Bergen PJ; Velkov T; Li J
J Antimicrob Chemother; 2015 Sep; 70(9):2589-97. PubMed ID: 26023209
[TBL] [Abstract][Full Text] [Related]
10. Evaluation of polymyxin B in combination with 13 other antibiotics against carbapenemase-producing Klebsiella pneumoniae in time-lapse microscopy and time-kill experiments.
Wistrand-Yuen P; Olsson A; Skarp KP; Friberg LE; Nielsen EI; Lagerbäck P; Tängdén T
Clin Microbiol Infect; 2020 Sep; 26(9):1214-1221. PubMed ID: 32224200
[TBL] [Abstract][Full Text] [Related]
11. Evaluation of Activity and Emergence of Resistance of Polymyxin B and ZTI-01 (Fosfomycin for Injection) against KPC-Producing Klebsiella pneumoniae.
Diep JK; Sharma R; Ellis-Grosse EJ; Abboud CS; Rao GG
Antimicrob Agents Chemother; 2018 Feb; 62(2):. PubMed ID: 29203494
[TBL] [Abstract][Full Text] [Related]
12. Combination of polymyxin B and minocycline against multidrug-resistant Klebsiella pneumoniae: interaction quantified by pharmacokinetic/pharmacodynamic modelling from in vitro data.
Zhao C; Wistrand-Yuen P; Lagerbäck P; Tängdén T; Nielsen EI; Friberg LE
Int J Antimicrob Agents; 2020 Jun; 55(6):105941. PubMed ID: 32171741
[TBL] [Abstract][Full Text] [Related]
13. Activity of polymyxin B combinations against genetically well-characterised Klebsiella pneumoniae producing NDM-1 and OXA-48-like carbapenemases.
Olsson A; Allander L; Shams A; Al-Farsi H; Lagerbäck P; Tängdén T
Int J Antimicrob Agents; 2023 Nov; 62(5):106967. PubMed ID: 37716575
[TBL] [Abstract][Full Text] [Related]
14. Evaluation of double- and triple-antibiotic combinations for VIM- and NDM-producing Klebsiella pneumoniae by in vitro time-kill experiments.
Tängdén T; Hickman RA; Forsberg P; Lagerbäck P; Giske CG; Cars O
Antimicrob Agents Chemother; 2014; 58(3):1757-62. PubMed ID: 24395223
[TBL] [Abstract][Full Text] [Related]
15. Synergy of polymyxin B and minocycline against KPC-3- and OXA-48-producing Klebsiella pneumoniae in dynamic time-kill experiments: agreement with in silico predictions.
Olsson A; Malmberg C; Zhao C; Friberg LE; Nielsen EI; Lagerbäck P; Tängdén T
J Antimicrob Chemother; 2024 Feb; 79(2):391-402. PubMed ID: 38158772
[TBL] [Abstract][Full Text] [Related]
16. Transcriptomic responses of a New Delhi metallo-β-lactamase-producing Klebsiella pneumoniae isolate to the combination of polymyxin B and chloramphenicol.
Abdul Rahim N; Cheah SE; Johnson MD; Zhu Y; Yu HH; Sidjabat HE; Butler MS; Cooper MA; Fu J; Paterson DL; Nation RL; Boyce JD; Bergen PJ; Velkov T; Li J
Int J Antimicrob Agents; 2020 Aug; 56(2):106061. PubMed ID: 32574791
[TBL] [Abstract][Full Text] [Related]
17. Evaluation Strategies for Triple-Drug Combinations against Carbapenemase-Producing Klebsiella Pneumoniae in an In Vitro Hollow-Fiber Infection Model.
Garcia E; Diep JK; Sharma R; Hanafin PO; Abboud CS; Kaye KS; Li J; Velkov T; Rao GG
Clin Pharmacol Ther; 2021 Apr; 109(4):1074-1080. PubMed ID: 33548079
[TBL] [Abstract][Full Text] [Related]
18. Model-informed dose optimisation of polymyxin-rifampicin combination therapy against multidrug-resistant Acinetobacter baumannii.
Zhao J; Zhu Y; Han ML; Lu J; Yu HH; Wickremasinghe H; Zhou QT; Bergen P; Rao G; Velkov T; Lin YW; Li J
Int J Antimicrob Agents; 2023 Sep; 62(3):106902. PubMed ID: 37380093
[TBL] [Abstract][Full Text] [Related]
19. Unveiling synergism of polymyxin B with chloramphenicol derivatives against multidrug-resistant (MDR) Klebsiella pneumoniae.
Idris N; Leong KH; Wong EH; Abdul Rahim N
J Antibiot (Tokyo); 2023 Dec; 76(12):711-719. PubMed ID: 37821539
[TBL] [Abstract][Full Text] [Related]
20. Polymyxin B in combination with meropenem against carbapenemase-producing Klebsiella pneumoniae: pharmacodynamics and morphological changes.
Sharma R; Patel S; Abboud C; Diep J; Ly NS; Pogue JM; Kaye KS; Li J; Rao GG
Int J Antimicrob Agents; 2017 Feb; 49(2):224-232. PubMed ID: 28040408
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
